3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck-MedSci.cn

3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck

Bourhis, J; Sun, X; Le Tourneau, C; Pointreau, Y; Sire, C; Kaminsky-Forrett, MC; Coutte, A; Alfonsi, M; Boisselier, P; Martin, L; Delord, JP; Clatot, F; Biau, J; Rolland, F; Gollmer, K; Szyldergemajn, SA; Even, C; Tao, Y

ANNALS OF ONCOLOGY, 2020; 31 (): S1168

科室
- - 订阅+
  - 更多科室
工具
服务